文献速递放射性药物与辐射防护核素与放射性配体治疗

COVID-19对全球核医学科的影响:2020年4月的一项国际调查

Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020.
PubMed 文献 · J Nucl Med · 2020-07-24

该网络问卷调查于2020年4月16日至5月3日开展,共分析来自72个国家的434份回复,评估COVID-19对核医学科的影响。结果显示诊断操作平均下降54%,其中PET/CT下降36%、骨显像下降60%、心肌研究下降66%、甲状腺研究下降67%;81%的中心开展放射性核素治疗,近4周平均减少45%;52%的站点限制99mTc/99Mo发生器采购;15%的受访者所在科室出现COVID-19感染。

要点

  • 诊断操作平均下降54%,PET/CT下降36%、骨显像下降60%、心肌研究下降66%、甲状腺研究下降67%。
  • 81%的中心开展放射性核素治疗,近4周平均减少45%,从拉丁美洲和东南亚的超过76%到韩国和新加坡的16%。
  • 52%的站点限制99mTc/99Mo发生器采购,12%暂时取消订单;15%的受访者所在科室出现COVID-19感染。

核心结论

  • 诊断和治疗性核医学操作急剧下降,世界各国受疫情影响程度相似。
  • 处于疫情高峰后阶段的国家(如韩国和新加坡)报告核医学服务受到的影响较小,但总体结果显示全球核医学服务受到显著影响。
  • 15%的受访者在其所在科室经历COVID-19感染。

研究设计与样本

  • 网络问卷调查,2020年4月16日至5月3日开放,共登记并分析来自72个国家的434份回复。
  • 问卷旨在评估疫情对住院和门诊核医学科的影响,包括操作数量、员工健康、放射性示踪剂和其他基本用品供应、个人防护装备可用性、运营方面和设施类型等。

主要发现

  • 诊断操作平均下降54%。
  • PET/CT扫描平均下降36%,前哨淋巴结操作下降45%,肺扫描下降56%,骨扫描下降60%,心肌研究下降66%,甲状腺研究下降67%。
  • 81%的参与中心开展放射性核素治疗,近4周平均减少45%,范围从拉丁美洲和东南亚的超过76%到韩国和新加坡的16%。
  • 52%的参与站点限制99mTc/99Mo发生器采购,12%暂时取消订单。
  • 报告基本材料(放射性同位素、发生器和药盒)供应不足,尤其是99mTc/99Mo发生器和131I,尤其在非洲、亚洲和拉丁美洲。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The coronavirus disease 2019 (COVID-19) pandemic has placed significant challenges on health-care systems worldwide, whether in the preparation, response, or recovery phase of the pandemic. This has been primarily managed by dramatically reducing in- and outpatient services for other diseases and implementing infection prevention and control measures. The impact of the pandemic on nuclear medicine departments and their services has not yet been established. The aim of this online survey was to evaluate the impact of COVID-19 on nuclear medicine departments. Methods: A web-based questionnaire, made available from April 16 to May 3, 2020, was designed to determine the impact of the pandemic on in- and outpatient nuclear medicine departments, including the number of procedures, employee health, availability of radiotracers and other essential supplies, and availability of personal protective equipment. The survey also inquired about operational aspects and types of facilities as well as other challenges. Results: A total of 434 responses from 72 countries were registered and analyzed. Respondents reported an average decline of 54% in diagnostic procedures. PET/CT scans decreased by an average of 36%, whereas sentinel lymph-node procedures decreased by 45%, lung scans by 56%, bone scans by 60%, myocardial studies by 66%, and thyroid studies by 67%. Of all participating centers, 81% performed radionuclide therapies, and they reported a reduction of 45% on average in the last 4 wk, ranging from over 76% in Latin America and South East Asia to 16% in South Korea and Singapore. Survey results showed that 52% of participating sites limited their 99mTc/99Mo generator purchases, and 12% of them temporarily cancelled orders. Insufficient supplies of essential materials (radioisotopes, generators, and kits) were reported, especially for 99mTc/99Mo generators and 131I, particularly in Africa, Asia, and Latin America. Conclusion: Both diagnostic and therapeutic nuclear medicine procedures declined precipitously, with countries worldwide being affected by the pandemic to a similar degree. Countries that were in the postpeak phase of the pandemic when they responded to the survey, such as South Korea and Singapore, reported a less pronounced impact on nuclear medicine services; however, the overall results of the survey showed that nuclear medicine services worldwide had been significantly impacted. In relation to staff health, 15% of respondents experienced COVID-19 infections within their own departments.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Freudenberg LS, Paez D, Giammarile F, et al. Global Impact of COVID-19 on Nuclear Medicine Departments: An International Survey in April 2020. J Nucl Med. 2020. PMID: 32709733. doi:10.2967/jnumed.120.249821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。